EICHOR
● Enrolling By Invitation
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Condition: Chronic Spontaneous Urticaria · Sponsor: Celldex Therapeutics
About this study
The purpose of this extension study is to collect long-term efficacy and safety data on barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) who completed the treatment and follow-up periods of the Phase 3 clinical trials. This study will also fulfill the Celldex commitment to provide post-trial access to participants who have completed the phase 3 studies, where applicable.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (96)
| Cahaba Dermatology & Skin Health Center, LLC | Birmingham, Alabama, United States | — |
| Medical Research of Arizona | Scottsdale, Arizona, United States | — |
| Center for Dermatology & Plastic Surgery - Avacare | Scottsdale, Arizona, United States | — |
| Kern Research | Bakersfield, California, United States | — |
| Allergy and Asthma Associates of Southern California - Laguna Niguel - CRN | Laguna Niguel, California, United States | — |
| Dermatology Research Associates | Los Angeles, California, United States | — |
| LA Universal Research Center, Inc. | Los Angeles, California, United States | — |
| Encore Medical Research of Boynton Beach LLC | Boynton Beach, Florida, United States | — |
| Dolphin Medical Research | Doral, Florida, United States | — |
| Direct Helpers Research Center | Hialeah, Florida, United States | — |
| Deluxe Health Center | Miami Lakes, Florida, United States | — |
| Sarasota Clinical Research | Sarasota, Florida, United States | — |
+ 84 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07256392